Skip to main content
TipRanks
Go Ultimate75% OFF

Enveric Biosciences (SLZ0) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Enveric Biosciences has a market cap or net worth of EUR 6.15M. The enterprise value is EUR 1.05M.

Market Cap
EUR 6.15M
Enterprise Value
EUR 1.05M

Share Statistics

Enveric Biosciences has 4,475,884 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
4,475,884
Owned by Insiders
13.67%
Owned by Institutions
2.04%

Financial Efficiency

Enveric Biosciences’s return on equity (ROE) is -2.90 and return on invested capital (ROIC) is -210.04%.

Return on Equity (ROE)
-2.90
Return on Assets (ROA)
-2.38
Return on Invested Capital (ROIC)
-210.04%
Return on Capital Employed (ROCE)
-2.10
Revenue Per Employee
0
Profits Per Employee
-2.02M
Employee Count
6
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Enveric Biosciences is -0.24. Enveric Biosciences’s PEG ratio is -0.00.

PE Ratio
-0.24
PS Ratio
0.00
PB Ratio
1.19
Price to FCF
-0.74
Price to Operating Cash Flow
-0.74
PEG Ratio
-0.00

Income Statement

In the last 12 months, Enveric Biosciences had revenue of 0 and earned -12.13M in profits. Earnings per share was -36.24.

Revenue
0
Gross Profit
-200.86K
Operating Income
-8.77M
Pretax Income
-8.77M
Net Income
-12.13M
EBITDA
-8.57M
Earnings Per Share (EPS)
-36.24

Cash Flow

In the last 12 months, operating cash flow was -9.14M and capital expenditures 0, giving a free cash flow of -9.14M billion.

Operating Cash Flow
-9.14M
Free Cash Flow
-9.14M
Free Cash Flow per Share
-2.04

Dividends & Yields

Enveric Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-134.75%
Earnings Yield
-138.45%

Stock Price Statistics

Beta
-1.11
52-Week Price Change
0.00%
50-Day Moving Average
4.67
200-Day Moving Average
4.67
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Enveric Biosciences upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
―

Financial Position

Enveric Biosciences as a current ratio of 5.38, with Debt / Equity ratio of 0.00%

Current Ratio
5.38
Quick Ratio
5.38
Debt to Market Cap
0.00
Net Debt to EBITDA
0.55
Interest Coverage Ratio
-82777.81

Taxes

In the past 12 months, Enveric Biosciences has paid 3.36M in taxes.

Income Tax
3.36M
Effective Tax Rate
-0.38

Enterprise Valuation

Enveric Biosciences EV to EBITDA ratio is -0.13, with an EV/FCF ratio of -0.13.

EV to Sales
0.00
EV to EBITDA
-0.13
EV to Free Cash Flow
-0.13
EV to Operating Cash Flow
-0.13

Balance Sheet

Enveric Biosciences has EUR 5.61M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 5.61M billion.

Cash & Marketable Securities
EUR 5.61M
Total Debt
EUR 0.00
Net Cash
EUR 5.61M
Net Cash Per Share
EUR 1.25
Tangible Book Value Per Share
EUR 1.28

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%